MCQs - 2026-09

AI excels in the early, data-intensive stages of drug discovery, such as identifying potential drug targets, generating novel molecular structures, and optimizing lead compounds for efficacy and safety before preclinical testing.

Deep Learning models, exemplified by Google DeepMind's AlphaFold, have revolutionized structural biology by accurately predicting protein 3D structures from amino acid sequences, which is vital for understanding disease mechanisms and designing targeted therapies.

AI has significantly sped up the early stages of drug discovery, from target identification to lead optimization, by analyzing vast datasets and predicting molecular interactions more efficiently than traditional methods.

As of 2026, MOM-2 is still in the advanced stages of planning and development, with ISRO working on its design and payload. A launch is anticipated later in the decade.

MOM-2 is primarily envisioned as an orbiter mission, carrying advanced scientific instruments to further study the Martian surface features, atmospheric dynamics, and sub-surface composition.

Mangalyaan-2 (Mars Orbiter Mission 2) is the planned successor to India's successful Mars Orbiter Mission (MOM-1). It is currently in the advanced planning and development stages.

In India, the financial year (FY) runs from April 1st to March 31st. Therefore, FY27 refers to the financial year that began on April 1, 2026, and will end on March 31, 2027.

The services sector, which is a significant part of India's economy, along with increased government and private capital expenditure, is anticipated to drive the GDP growth in Q2 FY27.

Various economic agencies have projected India's GDP growth for Q2 FY27 to be around 7.2%, driven by robust domestic demand and government spending.

The PLI scheme for Green Hydrogen is a key component of the National Green Hydrogen Mission, launched by the Government of India to decarbonize the economy and reduce dependence on fossil fuel imports.